137 related articles for article (PubMed ID: 38657647)
1. Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations.
Fugazzola L; Deandrea M; Borgato S; Dell'Acqua M; Retta F; Mormile A; Carzaniga C; Gazzano G; Pogliaghi G; Muzza M; Persani L
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38657647
[TBL] [Abstract][Full Text] [Related]
2. Volume reduction rate of radiofrequency ablation in ≤ 2 cm Bethesda IV thyroid nodules.
Dong Y; Zhan W; Zhou J; Li N; Liu Z; Xia S; Ni X; Liu J; Zhang J; Xu S; Yang Z; Hua Q
Eur Radiol; 2024 Mar; 34(3):1597-1604. PubMed ID: 37665388
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
Chiang PL; Luo SD; Chang YH; Chou CK; Chi SY; Chen YF; Lin WC
Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855419
[TBL] [Abstract][Full Text] [Related]
4. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
[TBL] [Abstract][Full Text] [Related]
5. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
6. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency Ablation of Indeterminate Thyroid Nodules: The First North American Comparative Analysis.
Issa PP; Omar M; Issa CP; Buti Y; Hussein M; Aboueisha M; Abdelhady A; Shama M; Lee GS; Toraih E; Kandil E
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232815
[TBL] [Abstract][Full Text] [Related]
8. Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience.
Bisceglia A; Rossetto R; Garberoglio S; Franzin A; Cerato A; Maletta F; Papotti MG; Ghigo E; Pagano L; Maccario M; Garberoglio R
Front Endocrinol (Lausanne); 2021; 12():638880. PubMed ID: 34079521
[TBL] [Abstract][Full Text] [Related]
9. Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
Nishino M; Mateo R; Kilim H; Feldman A; Elliott A; Shen C; Hasselgren PO; Wang H; Hartzband P; Hennessey JV
Thyroid; 2021 Aug; 31(8):1253-1263. PubMed ID: 33813868
[No Abstract] [Full Text] [Related]
10. Single-session treatment of benign thyroid nodules with radiofrequency ablation: Results at 6 months in 24 patients.
Familiar Casado C; Merino Menendez S; Ganado Diaz T; Pallarés Gasulla R; Pazos Guerra M; Marcuello Foncillas C; Calle Pascual A
Endocrinol Diabetes Nutr (Engl Ed); 2020 Mar; 67(3):164-171. PubMed ID: 31439500
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation for Benign Nonfunctional Thyroid Nodules in Children: A Retrospective Study of 62 Patients with Over Four Years of Follow-Up.
Li L; Qiu X
Thyroid; 2022 May; 32(5):525-535. PubMed ID: 34915754
[No Abstract] [Full Text] [Related]
12. Initial Ablation Ratio Predicts Volume Reduction and Retreatment After 5 Years From Radiofrequency Ablation of Benign Thyroid Nodules.
Bernardi S; Cavallaro M; Colombin G; Giudici F; Zuolo G; Zdjelar A; Dobrinja C; De Manzini N; Zanconati F; Cova MA; Stacul F; Fabris B
Front Endocrinol (Lausanne); 2020; 11():582550. PubMed ID: 33597921
[TBL] [Abstract][Full Text] [Related]
13. An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules.
Taccogna S; Papini E; Novizio R; D'Angelo M; Turrini L; Persichetti A; Pontecorvi A; Guglielmi R
Front Endocrinol (Lausanne); 2022; 13():1078019. PubMed ID: 36531453
[TBL] [Abstract][Full Text] [Related]
14. Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses.
Rossi M; Lupo S; Rossi R; Franceschetti P; Trasforini G; Bruni S; Tagliati F; Buratto M; Lanza G; Damiani L; Degli Uberti E; Zatelli MC
Endocrine; 2017 Jul; 57(1):98-107. PubMed ID: 27623969
[TBL] [Abstract][Full Text] [Related]
15. Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study).
Cesareo R; Manfrini S; Pasqualini V; Ambrogi C; Sanson G; Gallo A; Pozzilli P; Pedone C; Crescenzi A; Palermo A
J Clin Endocrinol Metab; 2021 May; 106(6):1692-1701. PubMed ID: 33608728
[TBL] [Abstract][Full Text] [Related]
16. Five-Year Results of Radiofrequency and Laser Ablation of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group.
Bernardi S; Giudici F; Cesareo R; Antonelli G; Cavallaro M; Deandrea M; Giusti M; Mormile A; Negro R; Palermo A; Papini E; Pasqualini V; Raggiunti B; Rossi D; Sconfienza LM; Solbiati L; Spiezia S; Tina D; Vera L; Stacul F; Mauri G
Thyroid; 2020 Dec; 30(12):1759-1770. PubMed ID: 32578498
[No Abstract] [Full Text] [Related]
17. Solid benign thyroid nodules (>10 ml): a retrospective study on the efficacy and safety of sonographically guided ethanol ablation combined with radiofrequency ablation.
Zhu Y; Zhang M; Jin Z; Tian X; Zhang Y; Xie F; Song Q; Yan L; Jiang B; Tang J; Luo Y
Int J Hyperthermia; 2020; 37(1):157-167. PubMed ID: 32024398
[No Abstract] [Full Text] [Related]
18. Comparison between microwave ablation and bipolar radiofrequency ablation in benign thyroid nodules: differences in energy transmission, duration of application and applied shots.
Vorländer C; David Kohlhase K; Korkusuz Y; Erbelding C; Luboldt W; Baser I; Korkusuz H
Int J Hyperthermia; 2018; 35(1):216-225. PubMed ID: 30300014
[TBL] [Abstract][Full Text] [Related]
19. Determining an energy threshold for optimal volume reduction of benign thyroid nodules treated by radiofrequency ablation.
Deandrea M; Trimboli P; Mormile A; Cont AT; Milan L; Buffet C; Giovanella L; Limone PP; Poirée S; Leenhardt L; Russ G
Eur Radiol; 2021 Jul; 31(7):5189-5197. PubMed ID: 33409792
[TBL] [Abstract][Full Text] [Related]
20. Follow-Up Strategies for Thyroid Nodules with Benign Cytology on Ultrasound-Guided Fine Needle Aspiration: Malignancy Rates of Management Guidelines Using Ultrasound Before and After the Era of the Bethesda System.
Yoon JH; Lee HS; Kim EK; Moon HJ; Park VY; Kwak JY
Thyroid; 2019 Sep; 29(9):1227-1236. PubMed ID: 31359839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
